There are no surrogate markers of POLE mutation status; though some researchers have attempted to histologically identify differences in immune components such as tumour infiltrating lymphocytes (TILs) to indicate POLE status (evidence has suggested that an increase in these populations can indeed indicate POLE status) [11,12]. This evidence concerns the gene POLE and neoplasm.